The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Arcus Biosciences Inc COM 03969F109 77,969 5,049,786 SH   DFND   0 5,049,786 0
Armo Biosciences Inc COM 04225U104 45,442 1,214,700 SH   DFND   0 1,214,700 0
Arris Intl Inc SHS G0551A103 257,822 9,703,500 SH   DFND 1 0 9,703,500 0
Arsanis Inc COM 042873109 61,990 451,362 SH   DFND   0 451,362 0
Cloudera Inc COM 18914U100 22,905 1,061,420 SH   DFND   0 1,061,420 0
Denali Therapeutics Inc COM 24823R105 11,158 566,666 SH   DFND   0 566,666 0
Dropbox Inc CL A 26210C104 407 13,033 SH   DFND   0 13,033 0
Snap Inc CL A 83304A106 41,556 2,618,548 SH   DFND   0 2,618,548 0
Spero Therapeutics Inc COM 84833T103 15,853 1,112,473 SH   DFND   0 1,112,473 0
Square Inc CL A 852234103 1,446 29,400 SH   DFND 1 0 29,400 0
Zscaler Inc COM 98980G102 78,275 2,788,560 SH   DFND   0 2,788,560 0